Ole M. Bech Joins Anyo Labs as an Advisor

With a long track record of building relationships overseas and driving business for Novo Nordisk in clinical phases, Bech joins Anyo Labs to bring a big pharma perspective on how we can work to transform drug discovery. With a deep understanding of market forces, demands and clinical needs worldwide Ole will contribute to Anyo´s future development into various therapeutic areas.

We have already engaged in very fruitful discussions and worked on some key aspects of our business together where Ole's perspectives has been very valuable. - Albin Boman CEO